# Yan Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yan-li-4/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,482 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 38 |
| i10-index | 134 |
| Last Known Institution | University of Louisville |
| OpenAlex ID | https://openalex.org/A5100711311 |
| ORCID iD | 0000-0001-6021-1641 |
| Works | 300 |

## Researcher papers

- [Hepatogastroenterology](https://scholariq.org/papers/hepatogastroenterology/)
- [Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer](https://scholariq.org/papers/development-and-interpretation-of-a-pathomics-based-model-for-the-prediction-of/)
- [Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression](https://scholariq.org/papers/circular-rna-hsa-circ-0068871-regulates-fgfr3-expression-and-activates-stat3-by/)
- [CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients](https://scholariq.org/papers/chd1l-promotes-hepatocellular-carcinoma-progression-and-metastasis-in-mice-and/)
- [Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma](https://scholariq.org/papers/clinicopathologic-features-tumor-immune-microenvironment-and-genomic-landscape/)
- [miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma](https://scholariq.org/papers/mir-129-5p-targets-wnt5a-to-block-pkc-erk-nf-b-and-jnk-pathways-in-glioblastoma/)
- [The prognosis role of AJCC/UICC 8<sup>th</sup> edition staging system in gastric cancer, a retrospective analysis.](https://scholariq.org/papers/the-prognosis-role-of-ajcc-uicc-8-sup-th-sup-edition-staging-system-in-gastric/)
- [Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/tumor-mutational-burden-predicting-the-efficacy-of-immune-checkpoint-inhibitors/)
- [Chinese guidelines for treatment of adult primary immune thrombocytopenia](https://scholariq.org/papers/chinese-guidelines-for-treatment-of-adult-primary-immune-thrombocytopenia/)
- [High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients](https://scholariq.org/papers/high-throughput-screening-of-rare-metabolically-active-tumor-cells-in-pleural/)
- [Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD)](https://scholariq.org/papers/whole-exome-sequencing-wes-analysis-of-transformed-small-cell-lung-cancer-sclc/)
- [Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas](https://scholariq.org/papers/mechanism-exploration-and-model-construction-for-small-cell-transformation-in/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)

## Researcher university

- [University of Louisville](https://scholariq.org/institutions/university-of-louisville/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.